Sandbox endocarditis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:


==Empirical Antibiotic Therapy==
==Streptococci==
<SMALL><font color="#FF4C4C">'''▸ Click on the following categories to expand treatment regimens.'''</font></SMALL>
 
{|
| valign=top |
<div style="border-radius: 5px 5px 0 0; border: solid 1px #20538D; border-bottom: 0px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 70px; line-height: 30px; width: 250px; background: #A1BCDD; text-align: center;">
<font color="#FFF">
'''Native Valve Endocarditis Caused by Viridans Group Streptococci and Streptococcus bovis'''
</font>
</div>
 
<div class="mw-customtoggle-table11" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 70px; line-height: 30px; width: 250px; background: #4479BA;">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''Viridans Group Streptococci and Streptococcus bovis Highly Penicillin-Susceptible'''
</font>
</div>
 
<div class="mw-customtoggle-table12" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 70px; line-height: 30px; width: 250px; background: #4479BA;">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''Viridans Group Streptococci and Streptococcus bovis Relatively Penicillin Resistant (MIC >0.12 μg/mL- ≤ 0.5 μg/mL)'''
</font>
</div>
 
<div style="border-radius: 0 0 0 0; border: solid 1px #20538D; border-bottom: 0px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 70px; line-height: 30px; width: 250px; background: #A1BCDD; text-align: center;">
<font color="#FFF">
'''Prosthetic Valves Endocarditis Caused by Viridans Group Streptococci and Streptococcus Bovis'''
</font>
</div>
 
 
<div class="mw-customtoggle-table13" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 70px; line-height: 30px; width: 250px; background: #4479BA;">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''Viridans Group Streptococci and Streptococcus bovis Penicillin-susceptible strain (MIC ≤ 0.12 μg/mL)'''
</font>
</div>
 
<div class="mw-customtoggle-table14" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 70px; line-height: 30px; width: 250px; background: #4479BA;">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''Viridans Group Streptococci and Streptococcus bovis Penicillin relatively or fully resistant strain (MIC >0.12 μg/mL)'''
</font>
</div>


*Antibiotic therapy for subacute disease, and in those who have received antibiotics recently can be delayed waiting the results of blood cultures, as this delay allows an additional blood cultures without the confounding effect of empiric treatment, which is very important in determining the causing pathogens.<ref>{{Cite book  | last1 = Braunwald | first1 = Eugene | last2 = Bonow | first2 = Robert O. | title = Braunwald's heart disease : a textbook of cardiovascular medicin | date = 2012 | publisher = Saunders | location = Philadelphia | isbn = 978-1-4377-2708-1 | pages =  }}</ref>


*On the other hand, the rapid progression of acute cases necessitate the start of empirical treatment antibiotic therapy once the blood cultures have been collected.
<div class="mw-customtoggle-table15" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 70px; line-height: 30px; width: 250px; background: #4479BA;">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''Viridans Group Streptococci and Streptococcus bovis Relatively Penicillin-Resistant Streptococci, MIC 0.2–0.5 µg/ml'''
</font>
</div>


*Empirical therapy is needed for all likely pathogens, certain antibiotic agents, including aminoglycosides, is preferably avoided for its toxic effects.
<div class="mw-customtoggle-table16" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 70px; line-height: 30px; width: 250px; background: #4479BA;">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''Relatively Penicillin-Resistant Streptococci, (MIC > 0.5 µg/ml)'''
</font>
</div>


*Clinical course of infection beside the epidemiological features should be considered upon selecting empirical treatment regimen.
<div class="mw-customtoggle-table17" style="cursor: pointer; border-radius: 0 0 0 0; border: solid 1px #20538D; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 1px 1px rgba(255, 255, 255, 0.5), 0 1px 1px rgba(0, 0, 0, 0.5); height: 70px; line-height: 30px; width: 250px; background: #4479BA;">
<font color="#FFF">
&nbsp;&nbsp;▸&nbsp;&nbsp;'''Unable to tolerate Penicillin or Ceftriaxone'''
</font>
</div>


*Consultation with an infectious disease specialist for the selection of one of the antibiotic regimens is recommended(See therapy for culture-negative endocarditis). <ref>{{Cite journal  | last1 = Bonow | first1 = RO. | last2 = Carabello | first2 = BA. | last3 = Chatterjee | first3 = K. | last4 = de Leon | first4 = AC. | last5 = Faxon | first5 = DP. | last6 = Freed | first6 = MD. | last7 = Gaasch | first7 = WH. | last8 = Lytle | first8 = BW. | last9 = Nishimura | first9 = RA. | title = 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. | journal = J Am Coll Cardiol | volume = 52 | issue = 13 | pages = e1-142 | month = Sep | year = 2008 | doi = 10.1016/j.jacc.2008.05.007 | PMID = 18848134 }}</ref>


{|
{| valign=top |
|-
{| class="mw-collapsible mw-collapsed" id="mw-customcollapsible-table11" style="background: #FFFFFF;"
| valign=top |
| valign=top |
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:22em" cellpadding="0" cellspacing="0";
{| style="float: left; cellpadding=0; cellspacing= 0; width: 400px;"
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Native valve}}''
! style="height: 50px; line-height: 30px; background: #4479BA; border: 0px; font-size: 100%; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=center | {{fontcolor|#FFF|Native Valve Endocarditis Caused by Highly Penicillin-Susceptible Viridans Group Streptococci and Streptococcus bovis}}
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin sulbactam|Ampicillin-Sulbactam]] 3 g q6h IV x 4–6 weeks'''''<BR>''PLUS''<BR> ▸ '''''[[Gentamicin|Gentamicin sulfate]] 1 mg per kg q8h IV/IM x 4–6 weeks'''''
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''<u>Preferred Regimen</u>''''' ( 4 wks )
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''OR''
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
 
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''[[Vancomycin]] 15 mg per kg q12h IV x 4–6 weeks''''' <BR>''PLUS''<BR>▸ '''''[[Gentamicin|Gentamicin sulfate]] 1 mg per kg q8h IV/IM x 4–6 week''''' <BR>''PLUS''<BR>'''''[[Ciprofloxacin]] 500 mg q12h PO or 400 mg q12h IV x 4–6 weeks'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G sodium]] † 12–18 million U/24 h IV either continuously or in 4-6 equally divided doses x 4 Wks'''''<BR>''OR''<BR> ▸ '''''[[Ceftriaxone|Ceftriaxone sodium]] 2 g/24 h IV/IM in 1 dose x 4 Wks'''''
|-
|-
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Native valve pediatric dose}}''
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose }}''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Ampicillin sulbactam|Ampicillin-Sulbactam]]300 mg per kg per 24 h IV in 4–6 equally divided doses'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G sodium]] 200 000 U/kg q24h IV either continuously or in 4-6 equally divided doses x 4 Wks'''''<BR>''OR''<BR> ▸'''''[[Ceftriaxone]] 100 mg/kg q24 h IV/IM in 1 dose x 4 Wks'''''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''''[[Gentamicin]] 1 mg per kg q8h IV/IM'''''
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''<u>Alternative Regimen</u>''''' ( 2 wks )
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Vancomycin]] 40 mg per kg per 24 h in 2 or 3 equally divided doses '''''
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Ciprofloxacin]] 10-15 mg per kg q12h IV/PO'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G sodium]]‡ 12–18 million U/24 h IV either continuously or in 6 equally divided doses x 2 Wks'''''<BR>''OR''<BR> ▸ '''''[[Ceftriaxone|Ceftriaxone sodium]] 2 g/24 h IV/IM in 1 dose x 2 Wks'''''
|-
|-
|}
!style="padding: 0 5px; font-size: 80%; background: #F8F8FF" align=left | '''''PLUS'''''
 
{|
|-
|-
| valign=top |
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin| Gentamicin sulfate]] ฿ 3 mg/Kg per 24h 1 dose x 2 Wks'''''\
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float:left; width:22em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Prosthetic valve (early, ≤ 1y)}}''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''''[[Vancomycin]] 15 mg per kg q12h IV x 6'''''<BR>''PLUS''<BR>▸ '''''[[Gentamicin|Gentamicin sulfate]] 1 mg per kg q8h IV/IM x 2weeks'''''<BR>''PLUS''<BR>▸'''''[[Cefepime]] 2 g q8h IV x 6 weeks''''' <BR>''PLUS''<BR>▸ '''''[[Rifampin]] 300 mg q8h PO/IV x 6 weeks'''''
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
|-
|-
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Prosthetic valve pediatric dose}}''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | '''''[[Penicillin G sodium]] 200 000 U/kg q24h IV in 4-6 equally divided doses x 2 Wks'''''<BR>''OR''<BR> ▸'''''[[Ceftriaxone]] 100 mg/kg q24 h IV/IM in 1 dose x 2 Wks'''''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''''[[Vancomycin]] 40 mg per kg per 24 h IV in 2 or 3 equally divided doses'''''
!style="padding: 0 5px; font-size: 80%; background: #F8F8FF" align=left | '''''PLUS'''''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Gentamicin]] 1 mg per kg q8h IV/IM '''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin| Gentamicin sulfate]] 3 mg/Kg per 24h 1 dose or 3 equally divided doses x 2 Wks'''''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''''[[Cefepime]] 50 mg q8h IV '''''
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''<u>Alternative Regimen</u>'''''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Rifampin]] 20 mg per kg per 24 h PO/IV in 3 equally divided doses'''''
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
|-
|-
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Prosthetic valve (late—greater than 1 y) (same regimens as for native valve endocarditis with addition of [[rifampin]])}}''
|style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''[[Vancomycin|Vancomycin hydrochloride]] ¶ 15 mg/kg q12h IV x 4 Wks''''' <br> Doses should not to exceed 2 g/24 h unless concentrations in serum are inappropriately low
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ampicillin sulbactam|Ampicillin-Sulbactam]] 3 g q6h IV x 4–6 weeks'''''<BR>''PLUS''<BR>▸ '''''[[Gentamicin|Gentamicin sulfate]] 1 mg per kg q8h IV/IM x 4–6 weeks'''''<BR>''PLUS''<BR>▸ '''''[[Rifampin]] 300 mg q8h PO/IV x 6 weeks'''''
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''OR''
|style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left |▸'''''[[Vancomycin|Vancomycin hydrochloride]] 40 mg/kg per 24 h IV in 2–3 equally divided doses'''''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] 15 mg per kg q12h IV x 4–6 weeks'''''<BR>''PLUS''<BR>▸ '''''[[Gentamicin|Gentamicin sulfate]] 1 mg per kg q8h IV/IM x 4–6 weeks'''''<BR>''PLUS''<BR>▸ '''''[[Ciprofloxacin]] 500 mg q12h PO or 400 mg q12h IV x 4–6 weeks'''''<BR>''PLUS''<BR>▸ '''''[[Rifampin]] 300 mg q8h PO/IV x 6 weeks'''''
|}
|}
 
:Minimum inhibitory concentration ≤ 0.12 μg/mL.
:† Preferred in most patients >65 y or patients with impairment of 8th cranial nerve function or renal function.
 
:₳ Pediatric dose should not exceed that of a normal adult.
 
:‡ 2-wk regimen not intended for patients with known cardiac or extracardiac abscess or for those with creatinine clearance of <20 mL/min, impaired 8th cranial nerve function, or Abiotrophia, Granulicatella, or Gemella spp infection; gentamicin dosage should be adjusted to achieve peak serum concentration of 3-4 μg/mL and trough serum concentration of >1 μg/mL when 3 divided doses are used; nomogram used for single daily dosing.
 
:¶ Vancomycin therapy recommended only for patients unable to tolerate penicillin or ceftriaxone; vancomycin dosage should be adjusted to obtain peak (1 h after infusion completed) serum concentration of 30–45 μg/mL and a trough concentration range of 10–15 μg/mL
 
:฿ Other potentially nephrotoxic drugs (eg, nonsteroidal antiinflammatory drugs) should be used with caution in patients receiving gentamicin therapy. Although it is preferred that gentamicin (3 mg/kg) be given as a single daily dose to adult patients with endocarditis due to viridans group streptococci, as a second option, gentamicin can be administered daily in 3 equally divided doses.
|-
|-
|}
|}
|}
===<u>Native Valve Endocarditis Caused by Viridans Group Streptococci and Streptococcus bovis</u>===
<div class="mw-collapsible mw-collapsed">
===== Viridans Group Streptococci and Streptococcus bovis Highly Penicillin-Susceptible =====
<div class="mw-collapsible-content">
<div class="mw-collapsible mw-collapsed">
===== Viridans Group Streptococci and Streptococcus bovis Relatively Penicillin Resistant (MIC >0.12 μg/mL- ≤ 0.5 μg/mL)=====
<div class="mw-collapsible-content">


{|
{|
|-
|-
| valign=top |
| valign=top |
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float:left; width:22em" cellpadding="0" cellspacing="0";
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:48em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Suspected Bartonella, culture negative}}''
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Native Valve Endocarditis Caused by Strains of Viridans Group Streptococci and Streptococcus bovis Relatively Resistant to Penicillin (MIC >0.12 μg/mL- ≤ 0.5 μg/mL))}}''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftriaxone sodium]] 2 g per 24 h IV/IM in 1 dose x 6 weeks'''''<BR>''PLUS''<BR>▸ '''''[[Gentamicin|Gentamicin sulfate]] 1 mg per kg q8h IV/IM x 2 weeks'''''
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''<u>Preferred Regimen</u>'''''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |''WITH/WITHOUT''
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
|-
|-
|style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Doxycycline]] 100 mg per kg q12h IV/PO x 6 weeks'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G sodium]] 24 million U/24 h IV either continuously or in 4–6 equally divided doses x 4 wks'''''<BR>''OR''<BR> ▸ '''''[[Ceftriaxone]] 2 g/24 h IV/IM in 1 dose x 4 wks'''''
|-
|-
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Documented Bartonella, culture positive}}''
!style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ''PLUS''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Doxycycline]] 100 mg q12h IV or PO x 6 weeks'''''<BR>''PLUS''<BR>▸ '''''[[Gentamicin|Gentamicin sulfate]] 1 mg per kg q8h IV/IM x 2 weeks'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin|Gentamicin sulfate]] 3 mg/kg per 24 h IV/IM in 1 dose x 2 wks'''''
|-
|-
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Documented Bartonella, culture positive pediatric dose}}''
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Ceftriaxone]] 100 mg per kg per 24 h IV/IM once daily'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G sodium]] 300 000 U/kg per 24 h IV in 4–6 equally divided doses'''''<BR>''OR''<BR> ▸ '''''[[Ceftriaxone]] 100 mg/kg per 24 h IV/IM in 1 dose'''''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Gentamicin]] 1 mg per kg q8h IV/IM'''''
!style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ''PLUS''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Doxycycline]] 2–4 mg per kg per 24 h IV/PO in 2 equally divided doses'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin|Gentamicin sulfate]] 3 mg/kg per 24 h IV/IM in 1 dose or equally divided doses'''''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''''[[Rifampin]] 10 mg per kg q12h PO/IV'''''
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''<u>Alternative Regimen</u>'''''
|-
|-
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
|-
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin|Vancomycin hydrochloride]] 30 mg/kg per 24 h IV in 2 equally divided doses x 4 wks'''''
|-
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
|-
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin|Vancomycin hydrochloride]] 40 mg/kg per 24 h IV or in 2 or 3 equally divided doses'''''
|-
|}
|}
|}


</div></div>
===<u>Prosthetic Valves Endocarditis Caused by Viridans Group Streptococci and Streptococcus Bovis</u>===
<div class="mw-collapsible mw-collapsed">
===== Viridans Group Streptococci and Streptococcus bovis Penicillin-susceptible strain (MIC ≤ 0.12 μg/mL)=====
<div class="mw-collapsible-content">


{| class="wikitable" style="margin: 1em auto 1em auto"
{|
|+
|-
! Regimen || Dosage and Route || Duration(wk)
| valign=top |
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:48em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Penicillin-susceptible strain (MIC ≤ 0.12 g/mL)}}''
|-
|-
| ||'''''<u>Native valve</u>'''''||
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''<u>Preferred Regimen</u>'''''
|-
|-
| '''[[Ampicillin sulbactam|Ampicillin-Sulbactam]]'''||12 g per 24 h IV in 4 equally divided doses||4–6
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
|-
|-
| || ''''PLUS'''' ||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G sodium]] † 24 million U/24 h IV either continuously or in 4–6 equally divided doses x 6 wks'''''<BR>''OR''<BR> ▸ '''''[[Ceftriaxone]] 2 g/24 h IV/IM in 1 dose x 6 wks'''''
|-
|-
| '''[[Gentamicin|Gentamicin sulfate]]'''|| 3 mg per kg per 24 h IV/IM in 3 equally divided doses||4–6
|style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ''WITH OR WITHOUT''
|-
|-
| || ''OR'' ||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin|Gentamicin sulfate]] ‡ 3 mg/kg per 24 h IV/IM in 1 dose x 2 wks'''''
|-
|-
| '''[[Vancomycin]]'''||30 mg per kg per 24 h IV in 2 equally divided doses||4–6
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
|-
|-
| || ''''PLUS'''' ||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G sodium]] 300 000 U/kg per 24 h IV in 4–6 equally divided doses'''''<BR>''OR''<BR> ▸ '''''[[Ceftriaxone]] 100 mg/kg IV/IM once daily'''''
|-
|-
| '''[[Gentamicin|Gentamicin sulfate]]'''||3 mg per kg per 24 h IV/IM in 3 equally divided doses||4–6
|style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ''WITH OR WITHOUT''
 
|-
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Gentamicin]] 3 mg/kg per 24 h IV/IM, in 1 dose or 3 equally divided doses'''''
|-
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''<u>Alternative Regimen</u>'''''
|-
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
|-
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin|Vancomycin
hydrochloride]] 30 mg/kg per 24 h IV in 2 equally divided doses x 6 wks'''''
|-
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
|-
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''40 mg/kg per 24 h IV or in 2 or 3 equally divided doses'''''
|-
|}
|}
 
*Dosages recommended are for patients with normal renal function.
 
:† Penicillin or ceftriaxone together with gentamicin has not demonstrated superior cure rates compared with monotherapy with penicillin or ceftriaxone for patients with highly susceptible strain; gentamicin therapy should not be administered to patients with creatinine clearance of <30 mL/min.
 
:‡ Although it is preferred that gentamicin (3 mg/kg) be given as a single daily dose to adult patients with endocarditis due to viridans group streptococci, as a second option, gentamicin can be administered daily in 3 equally divided doses.
 
</div></div>
 
<div class="mw-collapsible mw-collapsed">
 
===== Viridans Group Streptococci and Streptococcus bovis Penicillin relatively or fully resistant strain (MIC >0.12 μg/mL)=====
 
<div class="mw-collapsible-content">
 
{|
|-
|-
| || ''''PLUS'''' ||
| valign=top |
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:48em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Penicillin relatively or fully resistant strain (MIC >0.12 >μg/mL))}}''
|-
|-
| '''[[Ciprofloxacin]]'''||1000 mg per 24 h PO or 800 mg per 24 h IV in 2 equally divided doses||4–6
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''<u>Preferred Regimen</u>'''''
|-
|-
| ||→'''Pediatric dose''':
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
*'''[[Ampicillin sulbactam|Ampicillin-Sulbactam]]''' 300 mg per kg per 24 h IV in 4–6 equally divided doses
*'''[[Gentamicin]]''' 3 mg per kg per 24 h IV/IM in 3 equally divided doses
*'''[[Vancomycin]]''' 40 mg per kg per 24 h in 2 or 3 equally divided doses
*'''[[Ciprofloxacin]]''' 20–30 mg per kg per 24 h IV/PO in 2 equally divided doses
|-
|-
| ||'''''<u>Prosthetic valve (early, ≤ 1y)</u>'''''||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G sodium]] 24 million U/24 h IV either continuously or in 4–6 equally divided doses x 6 wks'''''<BR>''OR''<BR> ▸ '''''[[Ceftriaxone]] 2 g/24 h IV/IM in 1 dose x 6 wks'''''
|-
|-
| '''[[Vancomycin]]'''||30 mg per kg per 24 h IV in 2 equally divided doses||6
|style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ''PLUS''
|-
|-
| ||''''PLUS''''||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin|Gentamicin sulfate]] 3 mg/kg per 24 h IV/IM in 1 dose x 6 wks'''''
|-
|-
| '''[[Gentamicin|Gentamicin sulfate]]'''||3 mg per kg per 24 h IV/IM in 3 equally divided doses||2
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
|-
|-
| ||''''PLUS''''||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G sodium]] 300 000 U/kg per 24 h IV in 4–6 equally divided doses'''''
|-
|-
|'''[[Cefepime]]'''||6 g per 24 h IV in 3 equally divided doses||6
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''<u>Alternative Regimen</u>'''''
|-
|-
| ||''''PLUS''''||
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
|-
|-
| '''[[Rifampin]]'''||900 mg per 24 h PO/IV in 3 equally divided doses||6
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin|Vancomycin hydrochloride]] 30 mg/kg per 24 h IV in 2 equally divided doses x 6 wks'''''
|-
|-
| ||→'''Pediatric dose''':
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
*'''[[Vancomycin]]''' 40 mg per kg per 24 h IV in 2 or 3equally divided doses
*'''[[Gentamicin]]''' 3 mg per kg per 24 h IV/IM in 3 equally divided doses
*'''[[Cefepime]]''' 150 mg per kg per 24 h IV in 3 equally divided doses
*'''[[Rifampin]]''' 20 mg per kg per 24 h PO/IV in 3 equally divided doses
|-
|-
| ||'''''<u>Prosthetic valve (late—greater than 1 y)</u>'''''||'''Same regimens as listed above for native valve endocarditis'''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | '''''[[Vancomycin|Vancomycin hydrochloride]] 40 mg/kg per 24 h IV or in 2 or 3 equally divided doses'''''
|-
|-
| ||'''''<u>Suspected Bartonella, culture negative</u>'''''
|}
|}
 
</div></div>
 
<div class="mw-collapsible mw-collapsed">
 
===== Viridans Group Streptococci and Streptococcus bovis Relatively Penicillin-Resistant Streptococci, MIC 0.2–0.5 µg/ml=====
 
<div class="mw-collapsible-content">
 
{|
|-
|-
|'''[[Ceftriaxone sodium]]'''||2 g per 24 h IV/IM in 1 dose||6
| valign=top |
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:48em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Relatively Penicillin-Resistant Streptococci, MIC 0.2–0.5 µg/ml}}''
|-
|-
| ||''''PLUS''''||
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''<u>Preferred Regimen</u>'''''
|-
|-
| '''[[Gentamicin|Gentamicin sulfate]]'''||3 mg per kg per 24 h IV/IM in 3 equally divided doses||2
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
|-
|-
| ||'''''with/without'''''||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G potassium]] 24 million U/24 h IV either continuously or in 4–6 equally divided doses X 4 Wks '''''<BR>''OR'' <BR>▸'''''[[Ceftriaxone]] 2 g/24 h IV/IM in 1 dose'''''
|-
|-
| '''[[Doxycycline]]'''||200 mg per kg per 24 h IV/PO in 2 equally divided doses||6
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | AND
|-
|-
| ||'''''<u>Documented Bartonella, culture positive</u>'''''||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | '''''[[Gentamicin]] 3 mg/kg I.M. or I.V. daily in divided doses q. 8 hr X 2 Wks  '''''
|-
|-
| '''[[Doxycycline]]'''||200 mg per 24 h IV or PO in 2 equally divided doses||6
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
|-
|-
| ||''''PLUS''''||
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G potassium]] 300 000 U/24 h IV in 4–6 equally divided doses X 4 Wks '''''<BR>''OR''<BR> ▸ '''''[[Ceftriaxone]] 100 mg/kg per 24 h IV/IM in 1 dose'''''
|-
|-
| '''[[Gentamicin|Gentamicin sulfate]]'''||3 mg per kg per 24 h IV/IM in 3 equally divided doses||2
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | AND
|-
|-
| ||→'''Pediatric dose''':
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | '''''[[Gentamicin]] 3 mg/kg per 24 h IV/IM in 1 dose or 3 equally divided doses X 2 Wks'''''
*'''[[Ceftriaxone]]''' 100 mg per kg per 24 h IV/IM once daily
*'''[[Gentamicin]]''' 3 mg per kg per 24 h IV/IM in 3 equally divided doses
*'''[[Doxycycline]]''' 2–4 mg per kg per 24 h IV/PO in 2 equally divided doses
*'''[[Rifampin]]''' 20 mg per kg per 24 h PO/IV in 2 equally divided doses
|-
|-
|}
|}
|}


</div></div>


<div class="mw-collapsible mw-collapsed">


==Therapy of Native Valve Endocarditis Caused by Highly Penicillin-Susceptible Viridans Group Streptococci and Streptococcus bovis==
=====Relatively Penicillin-Resistant Streptococci, (MIC > 0.5 µg/ml)=====
 
<div class="mw-collapsible-content">


{|
{|
|-
| valign=top |
| valign=top |
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:22em" cellpadding="0" cellspacing="0";
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:48em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Native Valve Endocarditis Caused by Highly Penicillin-Susceptible Viridans Group Streptococci and Streptococcus bovis}}''
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Relatively Penicillin-Resistant Streptococci,<br> MIC > 0.5 µg/ml, consider Enterococcal regimen}}''
|-
|-
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''Preferred Regimen'''''
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''<u>Preferred Regimen</u>'''''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''''[[penicillin G sodium]] 12–18 million U/24 h IV either continuously or in 4 or 6 equally divided doses x 4 weeks'''''<BR>''OR''<BR> ▸ '''''[[Ceftriaxone|Ceftriaxone sodium]] 2 g/24 h IV/IM in 1 dose x 4 weeks'''''
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
|-
|-
! style="padding: 0 5px; font-size: 80%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G potassium]] 24 million U/24 h IV either continuously or in 4–6 equally divided doses x 4 Wks '''''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[penicillin G sodium]] 200 000 U/kg q24h IV in 4–6 equally divided doses'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | PLUS
|-
|-
|style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Ceftriaxone]] 100 mg/kg q24 h IV/IM in 1 dose'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin]] 3 mg/kg I.M. or I.V. daily in divided doses q. 8 hr x 2 Wks  '''''
|-
|-
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''Alternative Regimen'''''
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
|-
|-
|style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''[[Penicillin G sodium]] 12–18 million U/24 h IV either continuously or in 6 equally divided doses x 2 weeks<BR>''OR''<BR> ▸'''''[[Ceftriaxone|Ceftriaxone sodium]] 2 g/24 h IV/IM in 1 dose x 2weeks'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Penicillin G potassium]] 24 million U/24 h IV either continuously or in 4–6 equally divided doses x 4 Wks '''''
|-
|-
|style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ''PLUS''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | PLUS
|-
|-
|style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |▸'''''[[Gentamicin|Gentamicin sulfate]] 3 mg/kg per 24 h IV/IM in 1 dose X 2 weeks'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Gentamicin]] 3 mg/kg I.M. or I.V. daily in divided doses q. 8 hr x 2 Wks  '''''
|-
|-
! style="padding: 0 5px; font-size: 80%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
|}
|}
 
</div></div>
 
<div class="mw-collapsible mw-collapsed">
 
=====Unable to tolerate Penicillin or Ceftriaxone=====
 
<div class="mw-collapsible-content">
 
{|
| valign=top |
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:48em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Unable to tolerate [[Penicillin G potassium|Aqueous crystalline penicillin G sodium]] or [[Ceftriaxone]] }}''
|-
|-
| style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[penicillin G sodium]] 200 000 U/kg q24h IV in 4–6 equally divided doses'''''
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''Preferred Regimen'''''
|-
|style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | '''''[[ceftriaxone]] 100 mg/kg q24 h IV/IM in 1 dose'''''
|-style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | ▸'''''[[Gentamicin]] 3 mg/kg per 24 h IV/IM in 1 dose or 3 equally divided doses'''
|-
|-
!style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | '''''Alternative Regimen'''''
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Adult dose}}''
|-
|-
|style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |▸ '''''[[Vancomycin|Vancomycin hydrochloride]] 15 mg/kg q12h IV x 4 weeks,doses not to exceed 2 g/24 h unless concentrations in serum are inappropriately low'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] 30 mg/kg per 24 h IV in 2 equally divided doses not to exceed 2 g/24 h, unless serum concentrations are inappropriately low '''''
|-
|-
! style="padding: 0 5px; font-size: 80%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
! style="padding: 0 5px; font-size: 95%; background: #F8F8FF" align=center | ''{{fontcolor|#6C7B8B|Pediatric dose}}''
|-
|-
|style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |▸'''''[[Vancomycin|Vancomycin hydrochloride]] 40 mg/kg per 24 h IV in 2–3 equally divided doses'''''
| style="font-size: 95%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] 40 mg/kg 24 h in 2 or 3 equally divided doses X 4 Wks '''''
|-
|-
|}
|}
|}
|}


==References==
</div></div>
{{Reflist|2}}

Revision as of 16:24, 5 March 2014

Streptococci

▸ Click on the following categories to expand treatment regimens.

Native Valve Endocarditis Caused by Viridans Group Streptococci and Streptococcus bovis

  ▸  Viridans Group Streptococci and Streptococcus bovis Highly Penicillin-Susceptible

  ▸  Viridans Group Streptococci and Streptococcus bovis Relatively Penicillin Resistant (MIC >0.12 μg/mL- ≤ 0.5 μg/mL)

Prosthetic Valves Endocarditis Caused by Viridans Group Streptococci and Streptococcus Bovis


  ▸  Viridans Group Streptococci and Streptococcus bovis Penicillin-susceptible strain (MIC ≤ 0.12 μg/mL)

  ▸  Viridans Group Streptococci and Streptococcus bovis Penicillin relatively or fully resistant strain (MIC >0.12 μg/mL)


  ▸  Viridans Group Streptococci and Streptococcus bovis Relatively Penicillin-Resistant Streptococci, MIC 0.2–0.5 µg/ml

  ▸  Relatively Penicillin-Resistant Streptococci, (MIC > 0.5 µg/ml)

  ▸  Unable to tolerate Penicillin or Ceftriaxone


Native Valve Endocarditis Caused by Highly Penicillin-Susceptible Viridans Group Streptococci and Streptococcus bovis
Preferred Regimen ( 4 wks )
Adult dose
Penicillin G sodium † 12–18 million U/24 h IV either continuously or in 4-6 equally divided doses x 4 Wks
OR
Ceftriaxone sodium 2 g/24 h IV/IM in 1 dose x 4 Wks
Pediatric dose ₳
Penicillin G sodium 200 000 U/kg q24h IV either continuously or in 4-6 equally divided doses x 4 Wks
OR
Ceftriaxone 100 mg/kg q24 h IV/IM in 1 dose x 4 Wks
Alternative Regimen ( 2 wks )
Adult dose
Penicillin G sodium‡ 12–18 million U/24 h IV either continuously or in 6 equally divided doses x 2 Wks
OR
Ceftriaxone sodium 2 g/24 h IV/IM in 1 dose x 2 Wks
PLUS
Gentamicin sulfate ฿ 3 mg/Kg per 24h 1 dose x 2 Wks\
Pediatric dose
Penicillin G sodium 200 000 U/kg q24h IV in 4-6 equally divided doses x 2 Wks
OR
Ceftriaxone 100 mg/kg q24 h IV/IM in 1 dose x 2 Wks
PLUS
Gentamicin sulfate 3 mg/Kg per 24h 1 dose or 3 equally divided doses x 2 Wks
Alternative Regimen
Adult dose
Vancomycin hydrochloride ¶ 15 mg/kg q12h IV x 4 Wks
Doses should not to exceed 2 g/24 h unless concentrations in serum are inappropriately low
Pediatric dose
Vancomycin hydrochloride 40 mg/kg per 24 h IV in 2–3 equally divided doses
Minimum inhibitory concentration ≤ 0.12 μg/mL.
† Preferred in most patients >65 y or patients with impairment of 8th cranial nerve function or renal function.
₳ Pediatric dose should not exceed that of a normal adult.
‡ 2-wk regimen not intended for patients with known cardiac or extracardiac abscess or for those with creatinine clearance of <20 mL/min, impaired 8th cranial nerve function, or Abiotrophia, Granulicatella, or Gemella spp infection; gentamicin dosage should be adjusted to achieve peak serum concentration of 3-4 μg/mL and trough serum concentration of >1 μg/mL when 3 divided doses are used; nomogram used for single daily dosing.
¶ Vancomycin therapy recommended only for patients unable to tolerate penicillin or ceftriaxone; vancomycin dosage should be adjusted to obtain peak (1 h after infusion completed) serum concentration of 30–45 μg/mL and a trough concentration range of 10–15 μg/mL
฿ Other potentially nephrotoxic drugs (eg, nonsteroidal antiinflammatory drugs) should be used with caution in patients receiving gentamicin therapy. Although it is preferred that gentamicin (3 mg/kg) be given as a single daily dose to adult patients with endocarditis due to viridans group streptococci, as a second option, gentamicin can be administered daily in 3 equally divided doses.












Native Valve Endocarditis Caused by Viridans Group Streptococci and Streptococcus bovis

Viridans Group Streptococci and Streptococcus bovis Highly Penicillin-Susceptible


Viridans Group Streptococci and Streptococcus bovis Relatively Penicillin Resistant (MIC >0.12 μg/mL- ≤ 0.5 μg/mL)
Native Valve Endocarditis Caused by Strains of Viridans Group Streptococci and Streptococcus bovis Relatively Resistant to Penicillin (MIC >0.12 μg/mL- ≤ 0.5 μg/mL))
Preferred Regimen
Adult dose
Penicillin G sodium 24 million U/24 h IV either continuously or in 4–6 equally divided doses x 4 wks
OR
Ceftriaxone 2 g/24 h IV/IM in 1 dose x 4 wks
PLUS
Gentamicin sulfate 3 mg/kg per 24 h IV/IM in 1 dose x 2 wks
Pediatric dose
Penicillin G sodium 300 000 U/kg per 24 h IV in 4–6 equally divided doses
OR
Ceftriaxone 100 mg/kg per 24 h IV/IM in 1 dose
PLUS
Gentamicin sulfate 3 mg/kg per 24 h IV/IM in 1 dose or equally divided doses
Alternative Regimen
Adult dose
Vancomycin hydrochloride 30 mg/kg per 24 h IV in 2 equally divided doses x 4 wks
Pediatric dose
Vancomycin hydrochloride 40 mg/kg per 24 h IV or in 2 or 3 equally divided doses

Prosthetic Valves Endocarditis Caused by Viridans Group Streptococci and Streptococcus Bovis

Viridans Group Streptococci and Streptococcus bovis Penicillin-susceptible strain (MIC ≤ 0.12 μg/mL)
Penicillin-susceptible strain (MIC ≤ 0.12 g/mL)
Preferred Regimen
Adult dose
Penicillin G sodium † 24 million U/24 h IV either continuously or in 4–6 equally divided doses x 6 wks
OR
Ceftriaxone 2 g/24 h IV/IM in 1 dose x 6 wks
WITH OR WITHOUT
Gentamicin sulfate ‡ 3 mg/kg per 24 h IV/IM in 1 dose x 2 wks
Pediatric dose
Penicillin G sodium 300 000 U/kg per 24 h IV in 4–6 equally divided doses
OR
Ceftriaxone 100 mg/kg IV/IM once daily
WITH OR WITHOUT
Gentamicin 3 mg/kg per 24 h IV/IM, in 1 dose or 3 equally divided doses
Alternative Regimen
Adult dose
Vancomycin hydrochloride 30 mg/kg per 24 h IV in 2 equally divided doses x 6 wks
Pediatric dose
40 mg/kg per 24 h IV or in 2 or 3 equally divided doses
  • Dosages recommended are for patients with normal renal function.
† Penicillin or ceftriaxone together with gentamicin has not demonstrated superior cure rates compared with monotherapy with penicillin or ceftriaxone for patients with highly susceptible strain; gentamicin therapy should not be administered to patients with creatinine clearance of <30 mL/min.
‡ Although it is preferred that gentamicin (3 mg/kg) be given as a single daily dose to adult patients with endocarditis due to viridans group streptococci, as a second option, gentamicin can be administered daily in 3 equally divided doses.
Viridans Group Streptococci and Streptococcus bovis Penicillin relatively or fully resistant strain (MIC >0.12 μg/mL)
Penicillin relatively or fully resistant strain (MIC >0.12 >μg/mL))
Preferred Regimen
Adult dose
Penicillin G sodium 24 million U/24 h IV either continuously or in 4–6 equally divided doses x 6 wks
OR
Ceftriaxone 2 g/24 h IV/IM in 1 dose x 6 wks
PLUS
Gentamicin sulfate 3 mg/kg per 24 h IV/IM in 1 dose x 6 wks
Pediatric dose
Penicillin G sodium 300 000 U/kg per 24 h IV in 4–6 equally divided doses
Alternative Regimen
Adult dose
Vancomycin hydrochloride 30 mg/kg per 24 h IV in 2 equally divided doses x 6 wks
Pediatric dose
Vancomycin hydrochloride 40 mg/kg per 24 h IV or in 2 or 3 equally divided doses
Viridans Group Streptococci and Streptococcus bovis Relatively Penicillin-Resistant Streptococci, MIC 0.2–0.5 µg/ml
Relatively Penicillin-Resistant Streptococci, MIC 0.2–0.5 µg/ml
Preferred Regimen
Adult dose
Penicillin G potassium 24 million U/24 h IV either continuously or in 4–6 equally divided doses X 4 Wks
OR
Ceftriaxone 2 g/24 h IV/IM in 1 dose
AND
Gentamicin 3 mg/kg I.M. or I.V. daily in divided doses q. 8 hr X 2 Wks
Pediatric dose
Penicillin G potassium 300 000 U/24 h IV in 4–6 equally divided doses X 4 Wks
OR
Ceftriaxone 100 mg/kg per 24 h IV/IM in 1 dose
AND
Gentamicin 3 mg/kg per 24 h IV/IM in 1 dose or 3 equally divided doses X 2 Wks
Relatively Penicillin-Resistant Streptococci, (MIC > 0.5 µg/ml)
Relatively Penicillin-Resistant Streptococci,
MIC > 0.5 µg/ml, consider Enterococcal regimen
Preferred Regimen
Adult dose
Penicillin G potassium 24 million U/24 h IV either continuously or in 4–6 equally divided doses x 4 Wks
PLUS
Gentamicin 3 mg/kg I.M. or I.V. daily in divided doses q. 8 hr x 2 Wks
Pediatric dose
Penicillin G potassium 24 million U/24 h IV either continuously or in 4–6 equally divided doses x 4 Wks
PLUS
Gentamicin 3 mg/kg I.M. or I.V. daily in divided doses q. 8 hr x 2 Wks
Unable to tolerate Penicillin or Ceftriaxone
Unable to tolerate Aqueous crystalline penicillin G sodium or Ceftriaxone
Preferred Regimen
Adult dose
Vancomycin 30 mg/kg per 24 h IV in 2 equally divided doses not to exceed 2 g/24 h, unless serum concentrations are inappropriately low
Pediatric dose
Vancomycin 40 mg/kg 24 h in 2 or 3 equally divided doses X 4 Wks